Literature DB >> 22422834

Subgroup analyses.

Andrew D Oxman.   

Abstract

Mesh：

Year:  2012        PMID： 22422834     DOI： 10.1136/bmj.e2022

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Bevacizumab vs ranibizumab-an appraisal of the evidence from CATT and IVAN.

Authors:  F G Ahfat; F H Zaidi
Journal:  Eye (Lond)       Date:  2013-03       Impact factor: 3.775

Review 2.  Prone position for acute respiratory failure in adults.

Authors:  Roxanna Bloomfield; David W Noble; Alexis Sudlow
Journal:  Cochrane Database Syst Rev       Date:  2015-11-13

3.  Helping people make well-informed decisions about health care: old and new challenges to achieving the aim of the Cochrane Collaboration.

Authors:  Andrew D Oxman
Journal:  Syst Rev       Date:  2013-09-20

4.  Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation.

Authors:  Torbjørn Wisløff; Gunhild Hagen; Marianne Klemp
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

5.  Does the use of the Informed Healthcare Choices (IHC) primary school resources improve the ability of grade-5 children in Uganda to assess the trustworthiness of claims about the effects of treatments: protocol for a cluster-randomised trial.

Authors:  Allen Nsangi; Daniel Semakula; Andrew D Oxman; Matthew Oxman; Sarah Rosenbaum; Astrid Austvoll-Dahlgren; Laetitia Nyirazinyoye; Margaret Kaseje; Iain Chalmers; Atle Fretheim; Nelson K Sewankambo
Journal:  Trials       Date:  2017-05-18       Impact factor: 2.279

6.  Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.

Authors:  D Prieto-Alhambra; A Judge; N K Arden; C Cooper; K W Lyles; M K Javaid
Journal:  Osteoporos Int       Date:  2013-06-28       Impact factor: 4.507

Review 7.  Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy.

Authors:  Warren Pearce; Sujatha Raman; Andrew Turner
Journal:  Trials       Date:  2015-09-01       Impact factor: 2.279

8.  A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation.

Authors:  Miney Paquette; Ahlam Mohammed Alotaibi; Robby Nieuwlaat; Nancy Santesso; Lawrence Mbuagbaw
Journal:  Syst Rev       Date:  2019-10-25

9.  Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials.

Authors:  Muhammad Shahzeb Khan; Muhammad Arbaz Arshad Khan; Simra Irfan; Tariq Jamal Siddiqi; Stephen J Greene; Stefan D Anker; Jayakumar Sreenivasan; Tim Friede; Ayman Samman Tahhan; Muthiah Vaduganathan; Gregg C Fonarow; Javed Butler
Journal:  ESC Heart Fail       Date:  2020-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.